These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38408281)

  • 21. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
    Markulev C; McGorry PD; Nelson B; Yuen HP; Schaefer M; Yung AR; Thompson A; Berger G; Mossaheb N; Schlögelhofer M; Smesny S; de Haan L; Riecher-Rössler A; Nordentoft M; Chen EYH; Verma S; Hickie I; Amminger GP
    Early Interv Psychiatry; 2017 Oct; 11(5):418-428. PubMed ID: 26279065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
    Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
    BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2020 Dec; 50(16):2673-2681. PubMed ID: 33198845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.
    Costanzo S; di Niro V; Di Castelnuovo A; Gianfagna F; Donati MB; de Gaetano G; Iacoviello L
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):906-11. PubMed ID: 23587470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.
    van der Gaag M; Smit F; Bechdolf A; French P; Linszen DH; Yung AR; McGorry P; Cuijpers P
    Schizophr Res; 2013 Sep; 149(1-3):56-62. PubMed ID: 23870806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Trajectories of Plasma Polyunsaturated Fatty Acids and Associations With Psychosis Spectrum Outcomes in Early Adulthood.
    Mongan D; Perry BI; Healy C; Susai SR; Zammit S; Cannon M; Cotter DR
    Biol Psychiatry; 2024 Nov; 96(10):772-781. PubMed ID: 38631425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis.
    Ostinelli EG; D'Agostino A; Shokraneh F; Salanti G; Furukawa TA
    BMJ Open; 2019 Oct; 9(10):e032726. PubMed ID: 31601607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
    Zhou X; Teng T; Zhang Y; Del Giovane C; Furukawa TA; Weisz JR; Li X; Cuijpers P; Coghill D; Xiang Y; Hetrick SE; Leucht S; Qin M; Barth J; Ravindran AV; Yang L; Curry J; Fan L; Silva SG; Cipriani A; Xie P
    Lancet Psychiatry; 2020 Jul; 7(7):581-601. PubMed ID: 32563306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
    Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
    Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis.
    Jang H; Park K
    Clin Nutr; 2020 Mar; 39(3):765-773. PubMed ID: 31010701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2011 Jun; (6):CD004718. PubMed ID: 21678345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis.
    Snipe RMJ; Brelis B; Kappas C; Young JK; Eishold L; Chui JM; Vatvani MD; Nigro GMD; Hamilton DL; Convit L; Carr A; Condo D
    Nutr Diet; 2024 Feb; 81(1):94-106. PubMed ID: 37545015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.
    Müller H; Laier S; Bechdolf A
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S17-25. PubMed ID: 25261211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.
    Davies C; Cipriani A; Ioannidis JPA; Radua J; Stahl D; Provenzani U; McGuire P; Fusar-Poli P
    World Psychiatry; 2018 Jun; 17(2):196-209. PubMed ID: 29856551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.